Anaqua macht ausländische Patentanmeldungen zu einem strategischen Vorteil für IP-Profis
18 avr. 2024 07h00 HE
|
Anaqua
BOSTON / MÜNCHEN, April 18, 2024 (GLOBE NEWSWIRE) -- Anaqua, der führende Anbieter von Innovations- und IP-Management-Technologien, kündigt die Weiterentwicklung seines Angebots für...
Anaqua transforme l’extension de brevets à l’international en avantage stratégique pour les professionnels de la PI
18 avr. 2024 07h00 HE
|
Anaqua
BOSTON, 18 avr. 2024 (GLOBE NEWSWIRE) -- Anaqua, le leader des technologies de gestion de la propriété intellectuelle (PI) pour les entreprises, les conseils et les administrations, annonce...
Isuzu Motors Limited Drives Forward with Anaqua as Intellectual Property Management Provider
16 avr. 2024 08h00 HE
|
Anaqua
Anaqua announces global commercial vehicle manufacturer Isuzu Motors as new intellectual property management software client.
GBT Technologies Adapts Pioneering Apollo Technology for Next-Generation Counter-Drone System
11 avr. 2024 08h30 HE
|
GBT Technologies Inc.
SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) (the “Company”) has recently announced the use in a testing scenario of its innovative Apollo computer vision...
Anaqua améliore sa plateforme de recherche de brevets AcclaimIP en ajoutant des capacités basées sur l'IA
08 avr. 2024 09h37 HE
|
Anaqua
BOSTON, 08 avr. 2024 (GLOBE NEWSWIRE) -- Anaqua, le leader des technologies de gestion de la propriété intellectuelle (PI) et de l’innovation, continue d'améliorer sa puissante plateforme de...
Anaqua Enhances AcclaimIP Patent Search with AI-Powered Capabilities
08 avr. 2024 09h37 HE
|
Anaqua
Anaqua revolutionizes patent search with AI-powered AcclaimIP. Explore over 100M patents worldwide with user-friendly interface and cutting-edge AI.
Bannix and GBT Partner to Bring Revolutionary Imaging Tech "VisionWave" to Market
28 mars 2024 10h03 HE
|
GBT Technologies Inc.
Enter into Binding Business Combination Agreement WEST HOLLYWOOD, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (“Bannix” or the “Company”) together with GBT Technologies,...
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
25 mars 2024 07h06 HE
|
Chemomab Therapeutics
Chemomab has gained a new EU patent for CM-101 covering its use in liver diseases including PSC, adding to the robust patent estate in major territories.
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
19 mars 2024 07h55 HE
|
Clearmind Medicine Inc.
A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:...
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
18 mars 2024 07h29 HE
|
SciSparc Ltd
TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of...